HEALTH-2007-2.4.1-3
HEALTH-2007-2.4.1-3
4 projects · €11,839,032 total EU contribution (project-level) · 36 participating organizations · 13 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€11,839,032
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (7)
- UK (5)
- AT (4)
- Italy (4)
- France (3)
- BE (2)
- CH (2)
- DK (2)
- Spain (2)
- FI (2)
- EL (1)
- Netherlands (1)
- SE (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III3 projects · ES
- .2 projects · IT
- UULM2 projects · DE
- AUH/S1 projects · DK
- BIOL1 projects · AT
- BRUNEL UNIVERSITY LONDON1 projects · UK
- CR-UK1 projects · UK
- DIAGENODE1 projects · BE
- ENS DE LYON1 projects · FR
- EPFL1 projects · CH
- UOA1 projects · EL
- IDIBELL-CERCA1 projects · ES
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Genomic Instability in Cancer and Precancer GENICA · 201630 | FP7 | €2,994,979 | €4,835,047 | Details |
Genomic instability and genomic alterations in pre-cancerous lesions and/or cancer GENINCA · 202230 | FP7 | €2,995,569 | €4,033,238 | Details |
The use of Methylated DNA Immunoprecipitation MeDIP in cancer for better clinical management CANCERDIP · 200620 | FP7 | €2,999,994 | €3,922,043 | Details |
Identification and characterization of novel human telomere-related biomarkers that aid cancer management by improving patient diagnosis, treatment selection, response monitoring, and drug development TELOMARKER · 200950 | FP7 | €2,848,490 | €3,683,902 | Details |